Clinical trial

HYPAZ: Hypertension Induced by Pazopanib

NCT01392352

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-04-01

PhasePHASE2

Study timeline

Study start (unknown)2011-04-01Date precision: month

Registry last updated2020-02-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Renal Cell Carcinomaunresolved

Soft Tissue Sarcomaunresolved

Glioblastomaunresolved

Ovarian Cancerunresolved

Cervical Cancerunresolved

Breast Cancerunresolved

Non-small Cell Lung Cancerunresolved

Small Cell Lung Cancerunresolved

Pancreatic Cancerunresolved

Melanomaunresolved

Gastrointestinal Cancerunresolved

Interventions

PazopanibDRUG · verified · RxNorm: pazopanib

Sponsors & collaborators

Cambridge University Hospitals NHS Foundation Trustlead sponsor

University of Cambridgecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01392352 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.